Search Results | Grifols

Showing 529 search results

Filter by

Filter by

search_filters (Optional)

Contents

Files

News

search_filters-check

Sort by

Newest Oldest A-Z Z-A

Egypt achieves self-sufficiency in plasma-derived medicines thanks to Grifols

December 4, 2025

Grifols appoints Tomás Dagá as Vice President of the board of Grifols Egypt (GEPD) and accelerates plasma self-sufficiency for 2026

November 27, 2025

Grifols brings together companies and organizations to address the challenges of employment for people with disabilities

November 26, 2025

Grifols receives expanded indication for THROMBATE III^® (antithrombin III [human]) label in U.S., strengthening treatment options for pediatric patients

November 18, 2025

Grifols’ Biotest receives first regulatory approval for its fibrinogen concentrate

November 13, 2025

Grifols Secures 95% of Investor Support to Improve Documentation Terms of Its €1.3 Billion 7.5% Secured Notes

November 12, 2025

Grifols Welcomes Fitch Ratings’ Outlook Revision to Positive and Affirmation of 'B+' Rating

November 7, 2025

Grifols reports quarterly revenues of EUR 1,865 million and group profit of EUR 127 million

November 4, 2025

Grifols earns Platinum rating in EcoVadis sustainability assessment

October 23, 2025

Grifols expands U.S. diagnostic manufacturing with a new facility in San Diego

October 16, 2025

Grifols’ Biotest launches Yimmugo^® in the United States

October 9, 2025

Grifols creates the Board of Directors' Strategy Committee

September 29, 2025

Show more results